UpTempo℠ AAV Platform Process Accelerates Time From Gene To Clinic

Summary: Catalent’s UpTempo AAV platform process offers clients accelerated timelines for producing their clinical materials. The scalable, CGMP-ready platform process can significantly reduce the time from gene to clinic through a simplified supply chain, increased development and manufacturing efficiencies, and standardized documentation.